Elissavet Kardami Selected Research

Elissavet Kardami Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 05/2007
6	Cardiomegaly (Heart Hypertrophy) 10/2011 - 01/2003
6	Ischemia 10/2009 - 02/2002
5	Cardiotoxicity 04/2019 - 07/2017
5	Hypertrophy 01/2014 - 01/2003
4	Heart Failure 04/2019 - 08/2004
4	Fibrosis (Cirrhosis) 01/2014 - 01/2003
4	Reperfusion Injury 09/2013 - 03/2002
3	Inflammation (Inflammations) 04/2019 - 10/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2018
2	Myocardial Infarction 01/2014 - 03/2002
2	Vascular Remodeling 10/2013 - 01/2003
2	Infections 09/2008 - 04/2003
2	Infarction (Infarctions) 01/2007 - 04/2004
1	Atherosclerosis 04/2019
1	Thrombosis (Thrombus) 04/2019
1	Depressive Disorder (Melancholia) 01/2018
1	Mental Disorders (Mental Disorder) 01/2018
1	ST Elevation Myocardial Infarction 12/2017
1	Hypertension (High Blood Pressure) 10/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013
1	Cardiomyopathies (Cardiomyopathy) 01/2013
1	Essential Hypertension 10/2011
1	Left Ventricular Dysfunction 08/2010
1	Ventricular Remodeling 09/2008
1	Hypoxia (Hypoxemia) 03/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2004
1	Carcinogenesis 01/2003
1	Coronary Occlusion 03/2002

Drug/Important Bio-Agent (IBA)

15	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019 - 02/2002
6	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019 - 04/2013
4	Pharmaceutical PreparationsIBA 04/2019 - 04/2013
3	Protein Isoforms (Isoforms)IBA 01/2011 - 08/2004
3	ConnexinsIBA 09/2008 - 01/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 12/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 12/2018
2	ResveratrolIBA 10/2013 - 10/2011
2	Connexin 43 (Connexin43)IBA 09/2008 - 01/2003
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2019
1	Heme Oxygenase-1IBA 12/2018
1	AntioxidantsIBA 10/2017
1	Conditioned Culture MediaIBA 01/2014
1	Biological ProductsIBA 01/2014
1	ProcollagenIBA 01/2014
1	Neutralizing AntibodiesIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Fibronectins (Fibronectin)IBA 01/2014
1	Hydralazine (Apresoline)FDA LinkGeneric 10/2013
1	AnthracyclinesIBA 04/2013
1	CalreticulinIBA 01/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2011
1	Phosphotransferases (Kinase)IBA 10/2011
1	Adenosine Monophosphate (AMP)IBA 10/2011
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2011
1	PolyphenolsIBA 10/2011
1	CholesterolIBA 08/2010
1	LipidsIBA 08/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2010
1	Cytochromes c (Cytochrome c)IBA 10/2009
1	Glucose (Dextrose)FDA LinkGeneric 03/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2004
1	AngiotensinsIBA 08/2004
1	Troponin T (Troponin T1)IBA 04/2004
1	Histones (Histone)IBA 04/2003
1	fostriecinIBA 01/2003
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2003
1	Okadaic AcidIBA 01/2003
1	calyculin AIBA 01/2003
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 03/2002
1	Protein Kinase CIBA 03/2002
1	chelerythrineIBA 03/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2020 - 04/2019
2	Therapeutics 12/2018 - 12/2017
1	Percutaneous Coronary Intervention 12/2017
1	Ligation 04/2004